Introduction

17
Traumatic brain injury is a growing and under recognized public health threat. The CDC 18 estimates nearly 2 million people sustain a traumatic brain injury (TBI) each year in the 19 United States, contributing to over 30% of all injury related deaths 1, 2 . In fact, TBI related 20 healthcare expenditures near 80 billion dollars annually with an average cost of 4 million 21 dollars per person surviving a severe TBI [3] [4] [5] . The impact of TBI is highlighted not only by 22 its high mortality rate but also by the significant long-term complications suffered by its 23 survivors with the progressive development of motor, cognitive, and behavioral disorders 24 [6] [7] [8] [9] [10] . Even subconcussive events, those resulting in subclinical brain dysfunction without 25 the typical symptoms of concussion, may lead to long-term neurologic impairment 11, 12 . 26
The immune response to TBI plays a fundamental role the development and progression 27 of subsequent neurodegenerative disease and represents a complex interplay between 28 the injured brain and the resident immune cells of the brain -the microglia 13 . The current 29 manuscript is focused on developing a cell-type-specific understanding of the microglial 30 response to injury over time. Here we highlight the major trends in gene expression in 31 response to TBI. 32
33
TBI triggers a robust pro-inflammatory response within the injured brain. The degree of 34 this initial pro-inflammatory response has significant value in predicting more long-term 35 outcomes after TBI [14] [15] [16] . Even after the acute inflammatory response has resolved, 36 several studies demonstrated residual long-lasting inflammation within the brain in both 37 animal models as well as in patients 17, 18 . One of the main drivers of this continued 38 inflammation is the persistence of activated microglia-characterized by thickening and 39 retraction of their ramified processes, increased IL-1 and IL-6 with concomitant decreases 40 in IL-4 and IL-10, and increased expression of pro-oxidant genes with a reduction of 41 growth and antioxidant genes. A recent study showed an increased inflammatory profile 42 of microglia that persisted for up to 12 months after injury in a murine model of TBI 19 . 43
Furthermore, this continued inflammation is associated with lesion volume expansion and 44 loss of neurons in the hippocampus [18] [19] [20] [21] [22] . Even once the acute inflammatory process has 45 resolved and infiltrated monocyte-derived macrophages are no longer present within the 46 injured brain, microglia have the potential to remain activated for years after the initial 47 insult 19, 23 . A functional consequence of this constitutive activation after brain trauma is 48 an exaggerated neuroinflammatory response to otherwise benign secondary stimuli such 49 a subsequent subclinical head injury 10, [24] [25] [26] [27] . This may be the mechanism by which 50 patients who have sustained a concussion are more susceptible to subsequent 51 concussions [28] [29] [30] . Nonetheless, the molecular mechanisms resulting in the constitutive 52 activation of microglia remain elusive 21 . Therefore, in the current study, we aimed to 53 study the transcriptional dynamics of constitutively activated microglia over the course of 54 brain injury. 55
56
The first step towards any cell-specific transcriptional analysis relies on obtaining 57 sufficient cells of interest with the highest purity. The historical standard for distinguishing 58 between microglia and infiltrating macrophages is immunohistochemistry. Although 59 immunohistochemistry is useful for assessing morphology, proliferation, and sites of 60 activation it has a number of drawbacks limiting its use 31 . Several investigative groups 61 have focused on this problem including column free magnetic separation and CD11b 62 immunomagnetic enrichment combined with the differential expression of CD45 with flow 63 cytometry [31] [32] [33] . However, CD45 expression has been reported to vary depending on the 64 pathologic condition; thus, reliable separation of microglia from peripheral myeloid cells 65 is impaired 34, 35 . To overcome this issue, fluorescently marked myeloid cells, such as 66
, have been used. However, these mice are on mixed 67 backgrounds, which could greatly affect the immune response. Furthermore, the 68 presence of contaminated nonclassical monocytes could not be excluded 36, 37 . Therefore, 69
we use head-shielded bone marrow chimeric mice with CD45.1 cells in the circulation 70 and CD45.2 microglia in the brain allowing definitive and unambiguous differentiation 71 between microglia and infiltrating bone-marrow derived myeloid cells as previously 72 described by our laboratory 38 . To the best of our knowledge, no cell-type-specific study 73 has been conducted to specifically identify transcriptional changes in isolated populations 74 of microglia over the course of TBI. In the current study we demonstrate that TBI-75 associated microglia adopt longitudinal changes in their transcriptional profile associated 76 with pathways linked to the development of motor, cognitive, and behavioral disorders. 77
78
Results
79
Global patterns of gene expression from isolated populations of 80 microglia over the time course of TBI
81
The neuroinflammatory response to TBI is central to both neuroprotection and 82 neurotoxicity after injury, but attempts to broadly target immune activation have been 83 unsuccessful in improving outcomes in TBI patients [39] [40] [41] [42] . Because of this, there has been 84 a growing interest in investigating the microglial transcriptome after brain injury. Attempts 85 thus far have been plagued by the use of whole brain homogenates rather than individual 86 cell types as well as the use of microarray analyses restricted to a limited number of genes 87 in the inflammatory response 43, 44 . Therefore, we combined our ability to discriminate and 88 sort microglia from infiltrating monocytes and macrophages with unbiased transcriptional 89 profiling (RNA-seq) on FACSorted microglia from 7, 30, and 90 days after TBI. We 90 defined 396 genes that change expression across the time course (see methods). We 91 clustered these differentially expressed genes into 4 main patterns of expression (Fig. 1) . 92 data has identified the Trem2-APOE pathway as a pivotal regulator of microglial 154 phenotype in both of these disease processes 45 . Therefore, we aimed to determine if the 155 Trem2-APOE pathway was a major regulator of microglial phenotype after TBI. However, 156 unlike other neurodegenerative processes, our data demonstrates no significant change 157 in TREM2 expression as well as a progressive decrease in APOE expression over the 158 course of TBI (Fig. 4) . These seemingly contradictory results emphasize the need for 159 microglia-specific transcriptional studies in the setting TBI. While our data failed to demonstrate a common pathway with Alzheimer's disease and 173 multiple sclerosis through Trem2-APOE, a closer examination of Cluster 2 (Fig. 1) revealed 174 a number of upregulated genes associated with long-term synaptic potentiation, including PTPN5 175 also known as STEP (STriatial-Enriched protein tyrosine Phosphatase). STEP is a brain-specific 176 phosphatase and is highly expressed within the cortex, hippocampus, and amygdala 46, 47 . Our data show that expression of STEP is progressively increased in microglia over time following TBI 178 (Fig. 5) . STEP is critical in the long-term depression, or weakening, of synaptic efficacy between 179 neurons-a process fundamental to learning, memory, and cognition 48, 49 . When STEP activity is . This disrupts synaptic function and contributes to cognitive deficits 49, 51 .
182
In fact, elevated STEP is associated with the pathophysiology of Alzheimer's disease, 183 schizophrenia, and ischemic brain injury in both human cortex and mouse models [52] [53] [54] [55] [56] [57] . These To adequately capture the heterogeneity and complexity of microglia at different stages 211 of injury, a comprehensive, genome-wide sampling of individual cell types is required 37, 66 . 212
A cell-specific delineation of innate immune function based on transcriptional profiling in 213
TBI has yet to be undertaken. Therefore, we combined our ability to discriminate and sort 214 microglia from infiltrating monocytes and monocyte-derived macrophages with unbiased 215 transcriptional profiling (RNA-seq) on FACSorted microglia. Our analysis identified 4 216 sequentially upregulated or downregulated gene clusters involved in processes such as 217 the host defense response, synaptic potentiation, lipid remodeling, and membrane 218 polarization each providing new insights into the biology of microglial activation over the 219 course of TBI (Fig. 1) . While there has recently been considerable recent interest in the 220
Trem2-APOE pathway in the generation of a neurodegenerative microglial phenotype in 221
Alzheimer's Disease and multiple sclerosis 45 , our data demonstrates no significant 222 change in Trem2 expression as well as a progressive decrease in APOE expression over 223 the course of TBI (Fig. 4) . However, an examination of cluster II revealed a number ofgenes associated with long-term synaptic potentiation, including PTPN5 also known as 225
STEP (STriatial-Enriched protein tyrosine Phosphatase). STEP is a brain-specific 226
phosphatase that is highly expressed within the striatum, cortex, hippocampus, and 227 amygdala 46, 47 . STEP is critical in the long-term depression, or weakening, of synaptic 228 efficacy between neurons-a process fundamental to learning, memory, and cognition 229 48, 49 . Elevated STEP is associated with the pathophysiology of Alzheimer's disease (AD), 230 schizophrenia, and ischemic brain injury in both human cortex and mouse models [52] [53] [54] [55] [56] [57] . 231
In fact, genetic knockout of STEP reverses many of the cognitive and behavioral deficits 232 in AD models 53, 67 . To the best of our knowledge, STEP expression has never been 233 studied within the context of TBI. Our RNA-seq analysis demonstrates a 13-fold increase 234 in microglial expression of STEP over the course of injury (Fig. 5) 
. Previous studies have 235
shown that STEP affects neuronal communication by opposing synaptic strengthening. 236
High levels of STEP are believed to disrupt synaptic function and to contribute to learning 237 deficits in neurodegenerative disease 52, 68 . When STEP activity is elevated, several 238 
Shielded Bone Marrow Chimeras
278
Bone marrow was aseptically harvested from tibias and femurs, from 8-week-old 279 B6.CD45.1 donor mice, erythrocytes were lysed and the cells were counted using a 280
Countess automated cell counter. 8 weeks old B6.CD45.2 mice received a single 1000-281 cGy γ-irradiation dose using a Cs-137-based Gammacell 40 irradiator. The mice heads 282 were shielded with a lead bar so as to deliver the irradiation to the body only. 6 hours 283 after shielded irradiation, busulfan (30 mg/kg) was administered to completely ablate the 284 bone marrow of the recipient mice. Donor bone marrow (CD45.1) was transplanted 12 285 hours after busulfan ablation. Shielded bone marrow chimeras were maintained on 286 antibiotics trimethoprim/sulfamethoxazole (40 mg/5 mg, respectively). Eight weeks after 287 irradiation, 95% of the circulating monocytes were of donor origin (Fig. 6) 
38
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Controlled cortical impact 303
Controlled cortical impact was induced as previously described by our laboratory 38 . In 304 brief, mice were anesthetized with 100 mg/kg Ketamine and 10 mg/kg Xylazine via 305 intraperitoneal injection. A 1cm scalp incision was performed and a 5mm craniectomy 306 was performed 2 mm left of the sagittal suture and 2 mm rostral to the coronal suture. 307
The dura was left intact. Mice were then placed in a stereotaxic operating frame and the 308 impactor (Leica Biosystems Inc., Buffalo Grove, IL) was maneuvered into position. A 309 controlled cortical impact was then applied with a 3mm impacting tip at a velocity of 2.5m/s 310 and an impacting depth of 2mm with the dwell time set at 0. Table 1) . Data were acquired on a BD FACSAria cell sorter (BD Biosciences, 332
San Jose, CA), and microglia were sorted for further analyses. "Fluorescence minus one" 333 controls were used when necessary to set up gates. Pelleted sorted cells were immediately 334 lysed in extraction buffer from a PicoPure RNA isolation kit (Arcturus Bioscience), andlysates were stored at -80°C until RNA was extracted. Analysis of the flow cytometric data 336 was performed using Flowjo software (TreeStar, Ashland, OR). 337 338 
RNA-seq analysis
353
Raw sequencing files were first de-multiplexed using bcl2fastq. The resulting fastq files 354 were trimmed of low-quality reads and bases, polyA tails, and adaptors using bbduk 355 (http://jgi.doe.gov/data-and-tools/bb-tools/). The trimmed fastq files were aligned to the 356 mouse reference genome (mm10, Genome Reference Consortium GRCm38) using the 357 STAR (Spliced Transcripts Alignment to a Reference) algorithm 70 . HTSeq was run on 358 the resulting BAM files to provide raw gene counts. Raw gene counts for each sample 359 were merged into a single gene expression table and normalized for read depth using 360 counts per million (CPM). The three highest quality samples, based on RNA quality and 361 library quality from each experimental group were included for subsequent analyses. For 362 the RNA-seq analysis, we focused on the expressed genes which were defined as average 363 log CPM (log2(CPM+1)) expression > 4 in each experimental group. For visualization, GENE-E 364 (https://software.broadinstitute.org/GENE-E/) was used to perform K-means clustering 365 (K=4) on differentially expressed genes across all time points as defined by ANOVA test 366 (p<0.05) across any two groups shown in the heatmap. Gene Ontology associations and 367 the related p-values were determined by GO analysis (by GOrilla-[Gene Ontology 368 enRIchment anaLysis and visuaLizAtion tool]). 369
71
. Pairwise differential genes between time points were determined using DEseq2. 370
Volcano plots were generated using the log2 fold change of normalized gene counts 371 between microglia at different time points on the x-axis and corresponding p-values (log10) from DEseq2 on the y-axis. Plots were generated using the ggplot2 package from 373 R Studio software. 374
375
Data Availability
376
The data that support the findings of this study are available from the corresponding 377 author on request. RNA sequencing data is available through the NCBI Sequence 378
Read Archive (SRA accession number: SRP160379). 379 380
